By Adam Van Heerden, NoCamels
Alzheimer’s Disease
currently affects between 30-35 million people around the world and
according to the Alzheimer’s Disease Facts and Figures Report, this
number will double by 2030.
Israeli
company Neuronix has developed what may be the most advanced
non-invasive treatment for the disease, which is so far incurable.
According
to Neuronix, its treatment, which involves magnetic stimulation to the
brain, can restore a patient’s cognitive ability to a state comparable
to that of two years before the treatment began.
“The greatest concern in the medical community”
According
to Eyal Baror, CEO of Neuronix, “Alzheimer’s Disease (AD) is one of the
greatest concerns in the medical community today. AD is the only
disease this widespread for which there is no cure, vaccine, or any
other way to stop it.”
According to the Facts and Figures Report,
Alzheimer’s is the sixth cause of death globally and the only one in
the top 10 that has not diminished, but rather increased by 66 percent
between 2000 and 2008.
A real “game changer”
Baror
is clear about the fact that neuroAD is not a cure. Nevertheless, he is
confident that neuroAD is bringing about “a real change in the battle
against AD.”
Continue reading.
No comments:
Post a Comment